.2
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the common stock, $0.01 par value per share, of Merrimack Pharmaceuticals, Inc., a Delaware corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Dated: September 24, 2019
| JFL PARTNERS FUND LP | |||
| By: | JFL Capital Management LP General Partner | ||
| By: | JFL Capital Holdings LLC General Partner | ||
| By: | /s/ Joseph F. Lawler | ||
| Name: | Joseph F. Lawler | ||
| Title: | Managing Member | ||
| JFL CAPITAL MANAGEMENT LP | |||
| By: | JFL Capital Holdings LLC General Partner | ||
| By: | /s/ Joseph F. Lawler | ||
| Name: | Joseph F. Lawler | ||
| Title: | Managing Member | ||
| JFL CAPITAL HOLDINGS LLC | |||
| By: | /s/ Joseph F. Lawler | ||
| Name: | Joseph F. Lawler | ||
| Title: | Managing Member | ||
| JFL CAPITAL MANAGEMENT LLC | |||
| By: | /s/ Joseph F. Lawler | ||
| Name: | Joseph F. Lawler | ||
| Title: | Managing Member | ||
| /s/ Joseph F. Lawler | |
|
JOSEPH F. LAWLER |